| Document Date: 2013-07-25 21:01:14
Open Document File Size: 91,91 KBShare Result on Facebook
City Atlanta / / Company Underlying Medical Condition 20 15 10 Alaska U.S. / Risk Group1 Risk Group / / Country United States / / IndustryTerm otitis media / / MedicalCondition renal failure Nephrotic syndrome Leukemia/Lymphoma / high IPD illness / Alcoholism Chronic liver disease / pneumonia / hypertension / bacteremia / Multiple myeloma / emphysema / S. pneumoniae infection / chronic obstructive pulmonary disease / invasive pneumococcal disease / Anatomic Asplenia Sickle cell disease / phagocytic disorders / Notifiable Diseases / cardiomyopathies / chronic granulomatous disease / †Including congestive heart failure / ††Diseases / T-lymphocyte deficiency / severe illness / human immunodeficiency virus infection / sinusitis / otitis media / Chronic heart disease† Chronic lung disease± Diabetes / meningitis / immunodeficiency** Chronic / asthma / / MedicalTreatment radiation therapy / Cochlear implant / immunosuppression / cochlear implants / vaccination / organ transplant / / Organization Advisory Committee on Immunization Practices / Department of Health / PPSV23 / Administration of PCV13 / / Person Louisa Castrodale / Joe McLaughlin / Ward Hurlburt / William J. Streur / / / Position CMO/Director / Commissioner Division of Public Health Ward Hurlburt / Commissioner Division of Public Health / / ProvinceOrState Alaska / / RadioStation Core / / Region Alaska U.S. / / Technology radiation / / URL http /
SocialTag |
New Vaccines Being Implemented in 2006